Literature DB >> 12518847

Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes.

Colin J Sutherland1, Ali Alloueche, Jill Curtis, Chris J Drakeley, Rosalynn Ord, Manoj Duraisingh, Brian M Greenwood, Margaret Pinder, David Warhurst, Geoffrey A T Targett.   

Abstract

Polymorphisms in two genes of Plasmodium falciparum (P. falciparum multidrug resistance 1 [pfmdr1] and P. falciparum chloroquine [CQ] resistance transporter [pfcrt]) are associated with CQ treatment failure. We found significant linkage disequilibrium between these loci among isolates from symptomatic Gambian children (P = 0.026) and strong selection for the resistance-associated alleles pfmdr1-86Tyr and pfcrt-76Thr in children with persistent or re-emerging P. falciparum trophozoites during post-treatment follow-up (P = 1.9 x 10(-7)). Therefore, this genotype is characteristic of resistant infections among our study population. Since the long-term public health impact of parasites carrying such resistant genotypes depends upon their transmissibility, we examined the prevalence of pfmdr1-86Tyr and pfcrt-76Thr among Gambian children harboring sexual stage parasites during post-treatment follow-up. Gametocytes that emerged after successful treatment with CQ were significantly more likely to be of this genotype than were those emerging after other treatments (P = 4.83 x 10(-4)), and were infective to Anopheles mosquitoes. Therapeutic success may thus be accompanied by public health failure as cured children pass resistance genes on to mosquitoes at an enhanced rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12518847     DOI: 10.4269/ajtmh.2002.67.578

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  46 in total

1.  Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay.

Authors:  A P H A Moers; R L Hallett; R Burrow; H D F H Schallig; C J Sutherland; A van Amerongen
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Submicroscopic Plasmodium falciparum infections before and after sulfadoxine-pyrimethamine and artesunate association treatment in Dienga, Southeastern Gabon.

Authors:  Fousseyni S Touré; Jérôme Mezui-Me-Ndong; Odile Ouwe-Missi-Oukem-Boyer; Benjamin Ollomo; Dominique Mazier; Sylvie Bisser
Journal:  Clin Med Res       Date:  2006-09

Review 3.  Transporters involved in resistance to antimalarial drugs.

Authors:  Stephanie G Valderramos; David A Fidock
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

4.  Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes.

Authors:  Andrea Ecker; Viswanathan Lakshmanan; Photini Sinnis; Isabelle Coppens; David A Fidock
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.

Authors:  Margaret Pinder; Colin J Sutherland; Fatoumatta Sisay-Joof; Jamila Ismaili; Matthew B B McCall; Rosalyn Ord; Rachel Hallett; Anthony A Holder; Paul Milligan
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.

Authors:  Steffen Borrmann; Ingrid Lundgren; Sunny Oyakhirome; Bénido Impouma; Pierre-Blaise Matsiegui; Ayola A Adegnika; Saadou Issifou; Jürgen F J Kun; David Hutchinson; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria.

Authors:  C T Happi; G O Gbotosho; O A Folarin; A Sowunmi; O M Bolaji; B A Fateye; D E Kyle; W Milhous; D F Wirth; A M J Oduola
Journal:  Parasitol Res       Date:  2006-07-28       Impact factor: 2.289

8.  Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Michele van Vugt; Al Brockman; Robert Hutagalung; Shalini Nair; Denae Nash; Pratap Singhasivanon; Tim J C Anderson; Sanjeev Krishna; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2006-04-26       Impact factor: 9.079

9.  Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.

Authors:  C T Happi; G O Gbotosho; O A Folarin; A Sowunmi; T Hudson; M O'Neil; W Milhous; D F Wirth; A M J Oduola
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

10.  Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.

Authors:  Rachel L Hallett; Colin J Sutherland; Neal Alexander; Rosalynn Ord; Musa Jawara; Chris J Drakeley; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett; Ali Alloueche
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.